As for the rest of the world, "We will, of course, always do as much as we can, consistent with our first obligation," he declared.
US Secretary of State Anthony Blinken and India's External Affairs Minister S. Jaishankar discussed Covid-19 and health cooperation last week and it had opened the possibility of Washington allowing vaccine raw materials to be exported.
Earlier this month, Serum Institute of India (SII) CEO Adar Poonawala appealed to Biden to allow the exports of vaccine raw materials. "If we are to truly unite in beating this virus, on behalf of the vaccine industry outside the US, I humbly request you to lift the embargo of raw material exports out of the US so that vaccine production can ramp up," he tweeted.
Price first tried to sidetrack the issue of restrictions on vaccine raw materials exports by claiming that the reporter had asked about intellectual property rights for vaccines and that it was a matter for the US Trade Representative (USTR).
But the reporter from a Western news service had in fact asked only about the raw materials.
The question clearly was, "We reported that they (India) have asked the US to lift a ban on the export of vaccine raw materials, which basically threatens to slow the country's vaccination drive. When will the administration decide on that?"
Price said, "You asked about intellectual property and certain controls. That was -- is within the purview of USTR."
The export controls do not, in fact, come under the jurisdiction of the USTR which deals only with the matters of intellectual property rights.
The Defence Production Act that has been invoked to boost vaccine production in the US is reported to curtail the export of raw materials needed elsewhere.
Price then said, "What I will say broadly is that the US first and foremost is engaged in an ambitious and effective and, so far, successful effort to vaccinate the American people. That campaign is well underway, and we're doing that for a couple of reasons.""Number one, we have a special responsibility to the American people. Number two, the American people, this country has been hit harder than any other country around the world -- more than 550,000 deaths, tens of millions of infections in this country alone," he said.
But Price conceded that the spread of the virus elsewhere is also a threat to everyone.
"The point the Secretary (Blinken) has made repeatedly is that as long as the virus is spreading anywhere, it is a threat to people everywhere."
But support his point about the America First vaccination policy he added, "So as long as the virus is spreading uncontrolled in this country, it can mutate and it can travel beyond our borders. That, in turn, poses a threat well beyond the US."
Price asserted that the US playing a "leadership role" in "seeking to contain the virus beyond our borders."
He cited the US rejoining the World Health Organisation and Washington's contribution of $2 billion to the COVAX facility that provides vaccines to developing countries and the promise of $2 billion more to it.
He also said that the US was sending vaccines to its neighbours Canada and Mexico.
He said, "When it comes to India, (there is the) the Quad and the arrangement with the Quad, including to increase production capacity in India."
The leaders of the Quad -- Biden and Prime Ministers Narendra Modi of India, Yoshihide Suga of Japan and Scott Morrison of Australia -- had agreed at their summit last month on a joint programme to supply Covid-19 vaccines to countries in the Indo-Pacific.
The vaccines manufactured by India with US and Japanese funding would be distributed with Australian logistics under the programme.
Biden's Spokesperson Jen Psaki last week also sidestepped a question about lifting the ban on vaccine raw materials speaking instead about the reaction of USTR Katherine Tai to the request from India and South Africa for waiving the intellectual property rights for the vaccine.
While not committing to waiver of intellectual property rights, Tai had given a hint of optimism saying that the inequities in the developing countries' access to vaccines was unacceptable and "extraordinary times require extraordinary leadership, communication, and creativity."
India has become the world's main supplier of vaccines because of the license granted to SII by Oxford and AstraZeneca for the vaccine developed by them.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.